A case report of Intramural myoma expulsion after vaginal delivery

Document Type : Case report


1 Assistant Professor, Department of Obstetrics and Gynecology, Women's Health Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Professor, Department of Obstetrics and Gynecology, Women's Health Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.


Introduction: Uterine leiomyomas are the most common benign uterine tumors, which  are also reported during pregnancy and labor. Myomectomy is the definitive treatment for this condition; however, this technique is prohibited during pregnancy and is less commonly applied during childbirth. Although several drug therapies are available for the treatment of this condition, none involve the complete removal of myoma. Therefore, in the current study, we present a specific treatment, which resulted in the vaginal expulsion of myoma.
Case report: A 25-year-old woman with a previous history of intramural myoma was referred to our center with complaints of vaginal bleeding and reports of a 48×47 cm mass within the uterine cavity two months after cesarean section. The patient was diagnosed with fibroid degeneration and was treated with progesterone and antibiotics; after 17 days, the myoma was expelled from the vagina.
Results: Migration of myoma from the uterine wall to the uterine cavity, which leads to the vaginal expulsion of myoma, is possible after treatment with antibiotics and high-dose progesterone (by reducing or cutting off the blood flow to the myoma) .Therefore, this treatment can be applied for correctly selected patients.


  1. Cunningham FG, Leveno KJ, Bloom SL, Hanth JC, Rouse DL, Spong CY. Williams obstetrics. 24th ed. New York: McGraw-Hill; 2014.
  2. Parker WH. Uterine fibroids. In: Berek JS, Berek DL. Berek & Novak's gynecology.15th ed. Philadelphia: Lippicott Williams &Wilkins; 2012. pp: 438-69.
  3. Breech LL, Rock JA. Leiomyomata uteri and myomectomy. [Rock JA, Jones III HW trans]. Te Linde's operative gynecology. Philadelphia: Lippicott Williams & Wilkins; 2008: 687-726.
  4. Tomasik P, Bomba-Opon D, Krupniewski L, Palczewski P, Wielgos M. Evaluation of uterine myomas during pregnancy using magnetic resonance imaging. Neuro Endocrinol Lett 2014; 35(4):262-4.
  5. Ehigiegba AE, Ande AB, Ojobo SI. Myomectomy during cesarian section. Int J Gynecol Obstet 2001; 75(1):21-5.
  6. Roman AS, Tabsh KM. Myomectomy at time of delivery: a retrospective cohort study. BMC Pregnancy Childbirth 2004; 4(1):14.
  7. Bagaria M, Suneja A, Vaid NB, Guleria K, Mishra K. Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial. Aust N Z J Obstet Gynaecol 2009; 49(1):77-83.
  8. Halder SK, Sharan C, Al-Hendy A. 1, 25- dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod 1 2012; 86(4):116.
  9. Kim CH, Kim SR, Lee HA, Kim SH, Chae HD, Kang BM. Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas. Hum Reprod 2011; 26(3):559-63.
  10. Michalska M, Palatyńska-Ulatowska A, Palatyński A, Mirowski M, Kaplińska K, NawrotModranka J, et al. Influence of antibiotic therapy on the level of selected angiogenic factors in patients with benign gynecologic tumors-- preliminary report. Pharmazie 201; 66(8):619-2
  11. van Riemsdijk VM, Graziosi GC, Veersema S, Bongers M. Vaginal myoma expulsion after NovaSure endometrial ablation. J Minim Invasive Gynecol 2009; 6(4):496-7.
  12. Tropeano G, Di Stasi C, Litwicka K, Romano D, Draisci G, Mancuso S. Uterrin artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil Steril 2004; 81(4):1055-61.